Omni Bridgeway reported A$135.8 million of proceeds from 20 investment completions in the September quarter, generating a 3.9x MOIC. Management fees rose 24% and Funds 4/5 Series II reached its full US$1 billion target, giving the legal finance manager a strong opening quarter.
- A$135.8 million from 20 full and partial completions
- 3.9x MOIC, versus a two-year trailing average of 2.5x
- Management fees rose 24% to A$10.7 million
- Funds 4/5 Series II closed at its US$1 billion target
- A$416.6 million pipeline across 46 exclusive term sheets
Strong September Quarter Returns
Omni Bridgeway Limited (ASX:OBL) began FY27 with a burst of realised returns, converting 20 full and partial investment completions into A$135.8 million of proceeds. The quarter produced a 3.9x multiple on invested capital, well above the 2.5x average for the past eight quarters, while fair value conversion reached 102%.
The result comprised 11 full completions and nine partial completions. Full completions generated a 3.3x MOIC and A$82.6 million of proceeds, while partial completions delivered a 5.3x MOIC and A$53.2 million. Including a legacy balance-sheet investment made in 2011 and finally closed after adverse costs were settled, the quarter's MOIC would have been 1.9x. OBL said it has no remaining balance-sheet investments.
Fees and Fundraising Gain Momentum
Management fees rose 24% from the same quarter last year to A$10.7 million. The figure excludes performance fees and carried interest, but provides the clearest recurring-fee measure in the update. Omni Bridgeway also received A$9.4 million in cash carried interest, with a further approximately A$8.6 million accrued on Series II funds but not yet distributed.
The fundraising milestone was equally important: Funds 4/5 Series II closed at its full US$1 billion target, with investors representing 99% of Series I commitments reinvesting and contributing more than half the new capital. The fund close had been anticipated in August fund close plans, which also reported a record FY26 and a pipeline worth A$407.8 million at that time.
New commitments reached A$87.1 million across nine new investments and additional opportunities in existing investments, with A$81.2 million of new fair value added. The forward pipeline now comprises 46 exclusive term sheets estimated at A$416.6 million if contracted. That is up from 43 term sheets worth A$407.8 million at the end of FY26, although the commitments remain conditional until confirmatory diligence is complete and legal fund agreements are signed.
Cash Position and Execution Tests
OBL-only cash and receivables stood at A$122.5 million at 30 September, including A$87.2 million of cash and A$35.3 million of receivables. Cash operating expenses were A$15.7 million for the quarter, below the pace implied by the full-year budget of A$72.5 million to A$75.0 million, producing a 68% cost coverage ratio.
The numbers are preliminary and unaudited, and the report is not earnings guidance. Accrued carried interest may also be subject to claw-back, while settlement discussions, expected awards and the exclusive-term-sheet pipeline carry varying degrees of uncertainty. Management expects fee growth to accelerate after the Series II close, but also expects operating expenses to rise in later quarters. The next portfolio report, due on 29 January 2027, should show whether the opening-quarter conversion rate and fundraising momentum can be sustained.
Bottom Line?
The opening quarter is strong on both realised returns and fee-generating scale, but the next test is turning the A$416.6 million pipeline and accrued carried interest into contracted and distributed cash.
Questions in the middle?
- How much of the A$416.6 million exclusive-term-sheet pipeline will become signed commitments?
- When will the approximately A$8.6 million of accrued Series II carried interest be distributed, and could later outcomes affect it?
- Can management fees continue rising as operating costs increase through FY27?